Product Description
For Type 1 Diabetes (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01908894)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Company: Ipsen
Company Location:
Company Founding Year: 1929
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Type 1 Diabetes
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01908894 |
NCT01908894 | P1 |
Completed |
Type 1 Diabetes |
2012-03-01 |
2019-03-19 |
Treatments |
|
NCT01686620 |
Humalog® | P2 |
Completed |
Type 1 Diabetes |
2013-06-01 |
2019-03-19 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|